Mutational analyses ofBRCA1 andBRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerRonit Shiri‐Sverdlov, Eitan Friedman, Peter J. Oefner et al.|Human Mutation|2000Cited by 53
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerRonit Shiri‐Sverdlov, Eitan Friedman, Peter J. Oefner et al.|Human Mutation|2000Cited by 4
First prospectively-designed outcome study in estrogen receptor (ER)+ breast cancer (BC) patients (pts) with N1mi or 1-3 positive nodes in whom treatment decisions in clinical practice incorporated the 21-gene recurrence score (RS) resultSalomon M. Stemmer, Noa Ben-Baruch, Lior Soussan‐Gutman et al.|Annals of Oncology|2016Cited by 3